| 【Fixed Income Research】EVERRE – How far can the spill-over reach? |
| 【公司研究】百胜中国 (9987 HK) – 长线增长指引符合预期，但咖啡业务可加速扩张 |
| 【Company Research】I-Mab BioPharma (IMAB US) – CD73 confirmed as a promising target for cancer immunotherapy |
| 【Company Research】CG Services (6098 HK) – Acquisition of R&F Property Services: quick wrap up is the key |
| 【Sector Research】China Express Delivery Sector – Easing ASP pressure in Aug to drive sector rebound |
| 【Company Research】HUTCHMED (13 HK) – A home-grown, global-facing Biopharma |
| 【公司研究】百胜中国 (9987 HK) – 疫情让利润再次受压，但中期展望保持乐观 |
| 【Sector Research】China Technology Sector – Apple Launch Event: iPhone 13/Watch 7 largely inline; no new AirPods 3 slightly disappointing |
| 【Company Research】AK Medical (1789 HK) – Big winner in National VBP |
| 【Sector Research】China Property Sector – NBS Aug data deteriorated rapidly |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
